Initiatives at Churchgate Station and Mahindra & Mahindra focus on early detection, public education, and tobacco-related cancer prevention
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
Declan brings over 25 years of expertise in the pharmaceutical and biotech sectors
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
More emphasis should be given on investing healthcare resources towards prevention of diseases rather than only focusing on diagnostic and therapeutic options
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
PICCOLO trial met its primary endpoint of objective response rate (ORR)
For the year 2022, Biocon bettered its score in all the four EcoVadis themes – Environment (70), Labor & Human Rights (70), Ethics (60), and Sustainable Procurement (60)
Subscribe To Our Newsletter & Stay Updated
